These studies should evaluate how the NKG2A/HLA-E interaction may influence the functionality of different immune effectors, such as NK and T lymphocytes [50], and its impact on the interaction of cancer cells with the stroma, as well as on the progression and the metastatic dissemination of the disease. This evidence concerns the gene HLA-E and cancer.